Larvol Delta - Annovis-Secures-DSMB-Approval-to-Advance-Pivotal-Phase-3-Trial-of-Buntanetap-in-Alzheimers-Disease

Posiphen (buntanetap) - Annovis Bio

https://www.globenewswire.com/news-release/2026/02/12/3237130/0/en/Annovis-Secures-DSMB-Approval-to-Advance-Pivotal-Phase-3-Trial-of-Buntanetap-in-Alzheimer-s-Disease.html

Feb 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next